Bulk Orders 20+ vials
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulk
GLP Collection
Eloralintide, also known as LY3841136, is an investigational peptide studied as a selective amylin receptor agonist. Disguised Alpha supplies this listing as a lyophilized research vial labeled 10 mg.
Bundle & save
Referral program · researchers save 10%, you earn 15% backThe compounds researchers order most, by verified order volume.
More ways to save
Volume pricing applies automatically from three vials and reaches 20% at twenty. Larger runs, institutional supply and custom timelines get a quote.
Ask about bulkVerified test results
Each batch is analyzed by ILS Laboratories, an independent ISO/IEC 17025 accredited lab, before release. Below is the report for lot EL01, summarized from the certificate the lab published.
This lot ships under its own published certificate. Open any certificate below, exactly as the lab released it.
Side by side
Technical specifications
Important research notice
Not for human, veterinary, or food use. This product is sold exclusively for laboratory research purposes. It is not intended to diagnose, treat, cure, or prevent any disease, and has not been evaluated by the FDA.
All referenced publications and registries are sourced from peer-reviewed journals and official registries. They are provided for educational reference only and are not product claims.
By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with all applicable laws and regulations.
Ready when you are
The lot on this page links to the signed certificate for that batch.
Lyophilized research material
Eloralintide, also known as LY3841136, is an investigational peptide studied as a selective amylin receptor agonist. Disguised Alpha supplies this listing as a lyophilized research vial labeled 10 mg. Its identity, format and quantity should be recorded separately from the results reported for a particular batch.
| Compound | Eloralintide |
|---|---|
| Research identifier | LY3841136 |
| Labeled content | 10 mg per vial |
| Format | Lyophilized peptide |
Eloralintide is an amylin analogue investigated for selective activity at amylin receptors, including AMY1. Amylin biology is distinct from the GIP and GLP-1 receptor biology associated with tirzepatide. This distinction helps researchers identify the correct literature and avoid confusing compounds that appear in the same metabolic research category.
No. Eloralintide, tirzepatide and retatrutide are different compounds. Eloralintide is associated with amylin receptor research. This page describes eloralintide alone, not a GLP-3 product or a tirzepatide combination.
This vial is labeled 10 mg eloralintide only. The separate GLP-2 TZ and Eloralintide blend is labeled 20 mg tirzepatide plus 5 mg eloralintide. The individual compound amounts and the number of components differ.
Use the certificate section on this page or the COA portal. Match the exact compound, vial strength and assigned lot. Read the test method and reported results; analytical purity does not by itself establish peptide quantity, sterility or suitability for any particular experiment.
No. Published studies and sponsor reports concern their own study materials and protocols. They do not establish the safety, efficacy or clinical equivalence of this research product.
Lilly research background on eloralintide and tirzepatide provides compound-level context. Read the Eloralintide research guide or compare the two-compound blend. For batch-specific questions, contact Disguised Alpha.
Primary research relevant to the named compound or clearly identified component is linked below. Experimental results depend on identity, model and formulation.
Examined the amylin receptor agonist as an investigational compound. Eloralintide and cagrilintide are distinct molecules.
Retain the product label and lot number with the research record. Review the matching certificate of analysis for test coverage and reported results. Identity, analytical purity, measured content, sterility and endotoxin testing are distinct assessments; one does not establish the others.
Follow the supplied label and your laboratory’s validated handling and storage procedures. Record the vehicle, concentration and preparation date where relevant. Dry-material stability does not establish the shelf life of a prepared solution.
The listed milligrams refer to material per vial, not concentration or administration instructions. A prepared solution has its own concentration and stability requirements. Verify the exact selected option and shipping lot.
Open the linked certificate for the assigned lot or use the COA portal. Check sample identity, methods, date and reported measurements. A report for another lot or formulation is not a substitute.
The references describe the materials and conditions used by their authors. They do not establish that this commercial formulation was tested. For blends, evidence on an individual component does not validate the finished mixture or establish synergy.
The current certificate is matched to the selected product option and assigned shipping batch.
Enable JavaScript to view the certificate for your selected option.
We share visit and purchase data with advertising partners to measure and show ads. Some US state laws, including California's, call that a sale or sharing of personal information. You can turn it off for this browser.
Ad sharing is on in this browser.
Saved in this browser only. For your account or other devices, email support@disguisedalpha.com. Privacy Policy